July 9, 2025|
AI
|5 months agoSwiss Health Insurance Grapples with Weight Loss Drug Costs
Swiss insurers express concerns over mounting costs as basic health insurance coverage of Wegovy leads to surge in prescriptions
AI
Generated IllustrationKey Takeaways
AI
- Basic health insurance in Switzerland began reimbursing Wegovy in March 2024.
- Reimbursement for Wegovy is currently authorized only until the end of February 2027.
- Obesity is officially classified as a chronic illness in Switzerland.
- In the first three months of 2025, insurers spent half of the total amount spent in the entire previous year on Wegovy.
By The Numbers
40,000
patients
43 million
CHF
250,000
doses
300 million
CHF
They Said
"If 2% of the adult population received Wegovy, the annual cost could reach CHF 300 million."
1
Costs Explode as Wegovy Demand Soars
2
Insurers Confront a Fiscal Timebomb
3
Switzerland Battles a Heavy Chronic Crisis
4